RBC Capital analyst Ben Hendrix raised the firm’s price target on Tenet Healthcare to $87 from $84 and keeps an Outperform rating on the shares. The company’s Q2 results were “solid” while its raised guidance demonstrated the management’s growing confidence in second-half momentum, especially for ambulatory surgery centers, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on THC: